Page last updated: 2024-08-24

meglumine antimoniate and Leishmaniasis, Mucocutaneous

meglumine antimoniate has been researched along with Leishmaniasis, Mucocutaneous in 66 studies

Research

Studies (66)

Timeframe	Studies, this research(%)	All Research%
pre-1990	12 (18.18)	18.7374
1990's	10 (15.15)	18.2507
2000's	11 (16.67)	29.6817
2010's	22 (33.33)	24.3611
2020's	11 (16.67)	2.80

Authors

Authors	Studies
Berman, J; Cayhuara, E; Gutiérrez, P; Molina, C; Paz, D; Sánchez, M; Soto, J; Soto, P	1
Bracho, V; Cunha, JLS; de Andrade, BAB; de Arruda, JAA; Guevara, JR; Martínez, I; Reyes, O; Sanchez, C; Tomo, S; Villarroel-Dorrego, M	1
Botella-Estrada, R; Garcías-Ladaria, J; Martínez-Doménech, A; Mateu-Puchades, A; Nadal-Lladó, C; Palacios-Diaz, RD; Quintero, A; Rocamora-Durán, V; Sahuquillo-Torralba, A; Salavert-Lleti, M; Santos-Alarcón, S; Unamuno-Bustos, B; Vila-Payeras, A	1
Goyonlo, VM; Taghavi, F; Vahabi-Amlashi, S	1
Botella-Estrada, R; Castro-Hernández, I; Chouman-Arcas, R; Garrido-Jareño, M; Gómez-Ruiz, MD; Llavador-Ros, M; López-Hontangas, JL; Molina-Moreno, JM; Pemán-García, J; Sahuquillo-Torralba, A; Salavert-Lleti, M	1
Bartoloni, A; Basile, G; Bresci, S; Cristofaro, G; Di Muccio, T; Gaiera, G; Gallo, O; Gradoni, L; Gramiccia, M; Locatello, LG; Maggiore, G; Novelli, A; Piccica, M; Vellere, I; Zammarchi, L	1
Cunha, RG; Giraldelli, GA; Maiolini, VM; Rabelo, IMMA; Sbroglio, LL; Tuccori, LP	1
Almeida, LDC; Arruda, S; Carvalho, EM; Figueiredo, LP; Lessa, MM; Magalhães, A	1
Elias, VM; Osorio-Arango, K; Pinart, M; Pinzón-Flórez, CE; Reveiz, L; Romero, GA; Rueda, JR; Silveira Maia-Elkhoury, AN; Tweed, JA	1
Bernabé, DG; Biasoli, ER; Botelho, MCB; Ferreira, LL; Fikaris, S; Miyahara, GI; Prado-Ribeiro, AC; Soubhia, AMP	1
Assis, TM; Carvalho, JP; Cota, G; Simões, TC	1
Brustolin, AÁ; de Castro, KR; Mota, CA; Pelloso, SM; Ramos-Milaré, ÁCFH; Silveira, TGV	1
Aguayo-Carreras, P; Cuenca-Barrales, C; Perez-López, I; Ruiz-Villaverde, R; Tercedor-Sanchez, J	1
Barroso, PA; Bracamonte, E; Cajal, P; Hashiguchi, Y; Hoyos, CL; Korenaga, M; Lauthier, JJ; Marco, JD; Quipildor, M; Uncos, A	1
Barroso, DH; Freire, GSM; Gomes, CM; Martins, SS; Motta, JOCD; Paula, CDR; Pereira, LIA; Porto, C; Sampaio, RNR; Silva, JSFE	1
Cupolillo, E; Dávila, AM; Ribeiro-Alves, M; Romero, GA; Torres, DC	1
Blum, JA; Hatz, C; Mosimann, V; Neumayr, A	1
Aoun, K; Badri, T; Ben Abda, I; Benmously-Mlika, R; Bouratbine, A; Chelbi, H; Fenniche, S; Hammami-Ghorbel, H; Mokhtar, I	1
Caro-Gutiérrez, D; Gamo Villegas, R; López-Estebaranz, JL; Pampín Franco, A; Pinedo, F	1
Barrio, A; Basombrio, MA; Beckar, J; Garcia Bustos, MF; Moreno, S; Parodi, C	1
Confort, EM; da Costa, DC; da Silva, AF; Madeira, Mde F; Martins, AC; Moreira, JS; Palmeiro, MR; Quintella, LP; Schubach, Ade O; Silva, Fda C; Valete-Rosalino, CM	1
Aguirre-Urizar, JM; Araluce-Iturbe, I; Crovetto-De la Torre, MA; Crovetto-Martínez, R; Orte-Aldea, C; Whyte-Orozco, J	1
Baños, I; Chicharro, C; Cuervas-Mons, V; García-Domínguez, J; Martinez-Ruiz, R; Múñez, E; Ramos, A; Suarez-Massa, D	1
Azzabi, S; Boukhris, I; Cherif, E; Kechaou, I	1
Albuquerque, DR; Cruz, AF; de Lacerda, JC; Ferreira Aguiar, MC; Leite, CF; Resende, RG	1
Handjani, F; Hatam, GR; Mohammadpour, I; Motazedian, MH	1
Barnabas, GA; Morrone, A; Padovese, V; Terranova, M; Toma, L	1
Buffet, PA; Caumes, E; Jauréguiberry, S; Jeddi, F; Mazier, D; Thellier, M	1
El Fékih, N; Fazaa, B; Kamoun, MR; Khaled, S; Kharfi, M; Sliti, N; Trabelsi, S	1
Figueroa, RA; Miranda, MC; Prager, M; Zea, DF	1
Brahn, E; Craft, N; Pegues, DA; Yao, Q	1
Araujo-Melo, MH; Araújo-Silva, M; Carmo, CN; Conceição-Silva, F; Meneses, AM; Moreira, JS; Oliveira, RV; Pimentel, MI; Salgueiro, MM; Schubach, AO; Valete-Rosalino, CM	1
Amarti, A; Harmouche, T; Iguermia, S; Mernissi, FZ; Mikou, O	1
Di Mauro, D; Petrillo, G; Viglianesi, A	1
Chrusciak Talhari, C; Chrusciak-Talhari, A; da Silva, RM; de Oliveira Penna, G; Dietze, R; Gadelha Yamashita, EP; Lima Machado, PR; Talhari, S	1
Karoui, S; Osman, AB; Zaraa, I	1
Abebe, Z; Dassoni, F; Morrone, A; Naafs, B	1
Arruda, D; Foss, NT; Motta, AC; Souza, CS	1
Bermúdez, H; Boelaert, M; Chappuis, F; Desjeux, P; Dujardin, JC; Garcia, L; Rojas, E	1
Alvarez, E; Bryceson, A; Campos, P; Chang, E; Cruz, M; Echevarria, J; Llanos-Cuentas, A; Rosales, E; Seas, C	1
Marsden, PD; Sampaio, RN; Veiga, JP; Wolff, ER	1
Barreto, AC; Cuba, CC; Llanos Cuentas, EA; Marsden, PD	1
Armas, JA; Moreno, G; Rezzano, S; Scorza, JV	1
Barreto, AC; Cuba, CC; Guerra, M; Magalhâes, A; Marsden, PD; Rocha, RA; Sampaio, RN	1
Avila, JL; Biondo, F; Convit, J; Monzón, H	1
Berman, JD; Franke, ED; Gasser, RA; Grögl, M; Magill, AJ; Oster, CN	1
Berman, J; Grogl, M; Hernandez, N; Mejia, H; Soto, J	1
Harto, A; Hilara, Y; Ledo, A; Miralles, ES; Moreno, R; Núñez, M	1
Escobar, MA; Saravia, NG; Weigle, KA	1
Barbosa Santos, EG; Barroso, JA; Brito, CM; Conceição, NF; Marzochi, MC; Pacheco, RS	1
Blackwell, JM; Cabrera, M; Castes, M; Convit, J; Shaw, MA; Trujillo, D	1
Cuba Cuba, CA; Howard, MK; Miles, MA; Ogunkolade, W	1
Anacleto, C; Andrade, AF; Ferreira, AV; Gazola, KC; Michalick, MS; Moreira, ES	1
Bagán, JV; Jiménez, Y; Milián, MA; Pérez, A; Scully, C	1
Barrios, AA; Cavé, A; Fournet, A; Hocquemiller, R; Muñoz, V	1
Franke, ED; Grogl, M; Thomason, TN	1
da Costa, CA; Dias, M; Genaro, O; Lima, Ade O; Magalhaes, PA; Mayrink, W; Melo, MN; Michalick, MS; Nascimento, E; Toledo, VP	1
Chapman, WL; Hanson, WL; Lovelace, JK; Waits, VB	1
Hanson, WL; Klayman, DL; Lovelace, JK; Vennerstrom, JL; Waits, VB	1
Dorea, JG; Holzbecher, J; Merchan-Hamann, E; Ryan, DE	1
Carvalho, EM; Costa, JL; Llanos-Cuentas, EA; Marsden, PD; Sampaio, RN; Veiga, JP	1
Chong, H	1
Marsden, PD	1
Costa, JM; Dorea, JG; Holzbecher, J; Marsden, PD; Ryan, DE	1
Barrios, LA; Costa, JM; Cuba, CC; Marsden, PD; Netto, EM; Vexenat, CO	1
Barral, A; Barreto, AC; Carvalho, EM; Costa, JM; Cuba, CC; Llanos-Cuentas, EA; Magalhães, AV; Marsden, PD; Netto, EM; Rosa, AC	1

Reviews

4 review(s) available for meglumine antimoniate and Leishmaniasis, Mucocutaneous

Article	Year
Interventions for American cutaneous and mucocutaneous leishmaniasis. The Cochrane database of systematic reviews, 2020, 08-27, Volume: 8 Topics: Administration, Oral; Adult; Antiprotozoal Agents; Azithromycin; BCG Vaccine; Female; Humans; Hyperthermia, Induced; Immunocompetence; Injections, Intramuscular; Injections, Intravenous; Interferon-gamma; Leishmaniasis Vaccines; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Pentoxifylline; Phosphorylcholine; Randomized Controlled Trials as Topic	2020
Lip leishmaniasis: a case series with molecular identification and literature review. BMC infectious diseases, 2017, 01-25, Volume: 17, Issue:1 Topics: Adult; Aged; Animals; Child; Child, Preschool; Diagnosis, Differential; Female; Humans; Iran; Leishmania infantum; Leishmaniasis, Mucocutaneous; Lip; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Psychodidae; Treatment Outcome	2017
Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis. International journal of dermatology, 1986, Volume: 25, Issue:10 Topics: Allopurinol; Aminoquinolines; Antimony; Antimony Sodium Gluconate; Cryosurgery; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Levamisole; Liposomes; Meglumine; Meglumine Antimoniate; Metronidazole; Nifurtimox; Organometallic Compounds; Phenothiazines; Rifampin	1986
Mucosal leishmaniasis ("espundia" Escomel, 1911). Transactions of the Royal Society of Tropical Medicine and Hygiene, 1986, Volume: 80, Issue:6 Topics: Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Granuloma; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1986

Trials

6 trial(s) available for meglumine antimoniate and Leishmaniasis, Mucocutaneous

Article	Year
A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis. Revista da Sociedade Brasileira de Medicina Tropical, 2019, Mar-28, Volume: 52 Topics: Antiprotozoal Agents; Female; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Middle Aged; Phosphorylcholine; Pilot Projects; Time Factors; Treatment Outcome	2019
[Miltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis]. Medicina, 2014, Volume: 74, Issue:5 Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Comparative Effectiveness Research; Female; Humans; Injury Severity Score; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Nasopharynx; Organometallic Compounds; Phosphorylcholine; Young Adult	2014
Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil. The American journal of tropical medicine and hygiene, 2011, Volume: 84, Issue:2 Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Female; Humans; Leishmania guyanensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Treatment Outcome; Young Adult	2011
Parenteral aminosidine is not effective for Peruvian mucocutaneous leishmaniasis. The American journal of tropical medicine and hygiene, 2007, Volume: 76, Issue:6 Topics: Adult; Animals; Antiprotozoal Agents; Humans; Infusions, Parenteral; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Nasal Mucosa; Organometallic Compounds; Paromomycin	2007
Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 20, Issue:1 Topics: Administration, Topical; Adolescent; Adult; Animals; Antiprotozoal Agents; Benzethonium; Drug Administration Schedule; Drug Therapy, Combination; Humans; Injections, Intramuscular; Injections, Intravenous; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Paromomycin	1995
Immunotherapy as a treatment of American cutaneous leishmaniasis: preliminary studies in Brazil. Parassitologia, 1992, Volume: 34, Issue:1-3 Topics: Adolescent; Adult; Aged; Animals; Brazil; Child; Child, Preschool; Female; Humans; Immunotherapy, Active; Leishmania; Leishmania guyanensis; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Protozoan Vaccines	1992

Other Studies

56 other study(ies) available for meglumine antimoniate and Leishmaniasis, Mucocutaneous

Article	Year
Treatment of Bolivian Leishmania braziliensis Cutaneous and Mucosal Leishmaniasis. The American journal of tropical medicine and hygiene, 2022, 01-24, Volume: 106, Issue:4 Topics: Antiprotozoal Agents; Bolivia; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Meglumine Antimoniate; Treatment Outcome	2022
Mucosal Leishmaniasis of the lip: Report of an Exuberant case in a Young man. Head and neck pathology, 2023, Volume: 17, Issue:2 Topics: Adult; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Lip; Male; Meglumine Antimoniate; Skin; Young Adult	2023
Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF-α inhibitors. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2023, Volume: 21, Issue:5 Topics: Antiprotozoal Agents; Humans; Immunologic Factors; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Meglumine Antimoniate; Retrospective Studies; Tumor Necrosis Factor Inhibitors	2023
Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis. International journal for parasitology. Drugs and drug resistance, 2019, Volume: 11 Topics: Antiprotozoal Agents; Humans; Iran; Leishmania tropica; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Nose; Thalidomide; Young Adult	2019
Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital. Parasites & vectors, 2020, Jan-13, Volume: 13, Issue:1 Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Amphotericin B; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Middle Aged; Retrospective Studies; Risk Factors; Spain; Young Adult	2020
Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 97 Topics: Administration, Intravenous; Aged; Amphotericin B; Antiprotozoal Agents; Argentina; Azoles; Drug Therapy, Combination; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Pentamidine; Recurrence	2020
Mucocutaneous leishmaniasis in a cocaine user: diagnostic and therapeutic knowledge. Revista da Sociedade Brasileira de Medicina Tropical, 2020, Volume: 53 Topics: Adult; Antiprotozoal Agents; Cocaine-Related Disorders; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate	2020
Case Report: Unusual Presentation of Pharyngeal Mucosal Leishmaniasis due to The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:4 Topics: Antiprotozoal Agents; Cytokines; Deglutition Disorders; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Macrophages; Male; Meglumine Antimoniate; Middle Aged; Nasopharynx; Oropharynx; Skin	2020
Tongue Nodule as Primary Manifestation of American Cutaneous Leishmaniasis in an Immunocompetent Patient. Head and neck pathology, 2021, Volume: 15, Issue:3 Topics: Antiprotozoal Agents; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Middle Aged; Tongue Diseases	2021
Estimating direct costs of the treatment for mucosal leishmaniasis in Brazil. Revista da Sociedade Brasileira de Medicina Tropical, 2021, Volume: 54 Topics: Antiprotozoal Agents; Brazil; Cost-Benefit Analysis; Humans; Leishmaniasis, Mucocutaneous; Meglumine Antimoniate	2021
Successful combined therapy with Glucantime™ and pentoxifylline for the nasal mucosal lesion recently developed in a leishmaniasis patient having untreated cutaneous lesion for seven decades. Parasitology international, 2021, Volume: 85 Topics: Aged; Brazil; Drug Therapy, Combination; Female; Humans; Leishmania; Leishmaniasis, Mucocutaneous; Meglumine Antimoniate; Pentoxifylline; Trypanocidal Agents	2021
Successful response to liposomal amphotericin B in mucosal leishmaniasis in glans resistant to intralesional pentavalent. International journal of dermatology, 2019, Volume: 58, Issue:7 Topics: Aged, 80 and over; Amphotericin B; Antiprotozoal Agents; Foreskin; Humans; Infusions, Intravenous; Injections, Intralesional; Leishmania; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Treatment Outcome	2019
Simultaneous occurrence of cutaneous and mucocutaneous leishmaniasis caused by different genotypes of Leishmania (Viannia) braziliensis. The Journal of dermatology, 2019, Volume: 46, Issue:9 Topics: Adult; Antiprotozoal Agents; Argentina; Genotype; Genotyping Techniques; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate	2019
Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil. Acta tropica, 2013, Volume: 126, Issue:2 Topics: Amino Acid Substitution; Animals; Antiprotozoal Agents; Base Sequence; Brazil; DNA, Protozoan; Drug Resistance; Genetic Markers; HSP70 Heat-Shock Proteins; Humans; Leishmania braziliensis; Leishmania guyanensis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Molecular Sequence Data; Mutation; Organometallic Compounds; Polymorphism, Genetic; Prognosis; Protozoan Proteins; Sequence Analysis, DNA; Treatment Outcome	2013
Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment. Infection, 2013, Volume: 41, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Retrospective Studies; Species Specificity; Switzerland; Travel; Treatment Outcome; Young Adult	2013
Mucosal leishmaniasis of the lip: an emerging clinical form in Tunisia. Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:6 Topics: Adolescent; Adult; Antiprotozoal Agents; Cheilitis; Combined Modality Therapy; Communicable Diseases, Emerging; Cryotherapy; Female; Humans; Leishmania infantum; Leishmania major; Leishmaniasis, Mucocutaneous; Lip; Lip Diseases; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Tunisia; Young Adult	2015
Mucosal leishmaniasis of the tongue caused by Leishmania infantum in an immunocompetent woman. International journal of dermatology, 2015, Volume: 54, Issue:1 Topics: Adult; Antiprotozoal Agents; Female; Humans; Immunocompetence; Leishmania infantum; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tongue Diseases	2015
Oral manifestations in the American tegumentary leishmaniasis. PloS one, 2014, Volume: 9, Issue:11 Topics: Antiprotozoal Agents; Female; Humans; Larynx; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mouth Diseases; Mouth Mucosa; Nose; Nose Diseases; Organometallic Compounds; Pharynx; Prognosis; Retrospective Studies	2014
Mucocutaneous leishmaniasis must be included in the differential diagnosis of midline destructive disease: two case reports. Oral surgery, oral medicine, oral pathology and oral radiology, 2015, Volume: 119, Issue:1 Topics: Adult; Aged; Amphotericin B; Antiprotozoal Agents; Combined Modality Therapy; Diagnosis, Differential; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mouth Diseases; Nose Diseases; Organometallic Compounds	2015
Mucosal leishmaniasis mimicking squamous cell carcinoma in a liver transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:3 Topics: Antiprotozoal Agents; Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Humans; Leishmania; Leishmaniasis, Mucocutaneous; Liver Transplantation; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mouth; Organometallic Compounds; Polymerase Chain Reaction	2015
Orofacial granulomatosis: do not forget leishmaniasis. BMJ case reports, 2015, Sep-02, Volume: 2015 Topics: Antiprotozoal Agents; Diagnosis, Differential; Granulomatosis, Orofacial; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Young Adult	2015
Mucosal leishmaniasis in Brazilian patients: two case reports with similar clinical presentation and different approaches. Oral surgery, oral medicine, oral pathology and oral radiology, 2016, Volume: 122, Issue:6 Topics: Aged, 80 and over; Amphotericin B; Antiprotozoal Agents; Brazil; Fatal Outcome; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mouth Mucosa; Organometallic Compounds; Polymerase Chain Reaction; Skin Tests	2016
Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2009, Volume: 103, Issue:7 Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Ethiopia; Female; HIV Infections; HIV-1; Humans; Infant; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Socioeconomic Factors; Young Adult	2009
Drug hypersensitivity syndrome induced by meglumine antimoniate. The American journal of tropical medicine and hygiene, 2009, Volume: 80, Issue:6 Topics: Adult; Antiprotozoal Agents; Drug Hypersensitivity; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Syndrome	2009
[Mucosal leishmaniasis by contiguity with a skin lesion: another case report from Tunisia]. Medecine tropicale : revue du Corps de sante colonial, 2008, Volume: 68, Issue:6 Topics: Antiprotozoal Agents; Female; Humans; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Tunisia	2008
[Mucosal complication of cutaneous leishmaniasis]. Biomedica : revista del Instituto Nacional de Salud, 2009, Volume: 29, Issue:1 Topics: Aged; Anemia; Antiprotozoal Agents; Contraindications; Eyelid Diseases; Humans; Hypertension; Kidney Failure, Chronic; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Lip Diseases; Male; Meglumine; Meglumine Antimoniate; Nose Diseases; Organometallic Compounds; Phosphorylcholine	2009
Mucocutaneous leishmaniasis masquerading as Wegener granulomatosis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2010, Volume: 16, Issue:3 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Brazil; California; Diagnosis, Differential; Female; Granulomatosis with Polyangiitis; Humans; Infusions, Intravenous; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Referral and Consultation	2010
Risk factors associated with dizziness during treatment of mucosal leishmaniasis with meglumine antimoniate: 16-year retrospective study of cases from Rio de Janeiro, Brazil. The Journal of laryngology and otology, 2010, Volume: 124, Issue:10 Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Dizziness; Dose-Response Relationship, Drug; Female; Humans; Leishmaniasis, Mucocutaneous; Lipase; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Odds Ratio; Organometallic Compounds; Retrospective Studies; Risk Factors; Sex Distribution; Young Adult	2010
[Mucocutaneous leishmaniasis in Morocco, evidence of the parasite's ecological evolution?]. Medecine et maladies infectieuses, 2011, Volume: 41, Issue:1 Topics: Adolescent; Africa; Antiprotozoal Agents; Biological Evolution; Cheilitis; Host-Parasite Interactions; Humans; Immunocompetence; Latin America; Leishmania; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Morocco; Organometallic Compounds; Species Specificity; Virulence	2011
Multidetector computed tomography aspects of tracheal mucosal leishmaniasis localization. Japanese journal of radiology, 2011, Volume: 29, Issue:1 Topics: Aged; Antiprotozoal Agents; Bronchoscopy; Contrast Media; Humans; Imaging, Three-Dimensional; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tomography, X-Ray Computed; Tracheal Diseases	2011
Effectiveness of intralesional meglumine antimoniate in the treatment of mucosal leishmaniasis of the Old World. The Journal of dermatology, 2012, Volume: 39, Issue:2 Topics: Adolescent; Adult; Antiprotozoal Agents; Humans; Injections, Intralesional; Leishmaniasis, Mucocutaneous; Lip; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2012
Cutaneous and mucocutaneous leishmaniasis resembling borderline-tuberculoid leprosy: a new clinical presentation? Acta dermato-venereologica, 2013, Volume: 93, Issue:1 Topics: Adolescent; Antiprotozoal Agents; Diagnosis, Differential; Endemic Diseases; Ethiopia; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Leprosy, Tuberculoid; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Young Adult	2013
Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid. International journal of dermatology, 2003, Volume: 42, Issue:9 Topics: Aged; Animals; Antiprotozoal Agents; Diagnosis, Differential; Facial Dermatoses; Humans; Immunocompromised Host; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prednisone; Pulmonary Disease, Chronic Obstructive	2003
Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia. Annals of tropical medicine and parasitology, 2006, Volume: 100, Issue:7 Topics: Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Bolivia; Drugs, Generic; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2006
Renal tubular dysfunction in patients with mucocutaneous leishmaniasis treated with pentavalent antimonials. Lancet (London, England), 1983, Sep-03, Volume: 2, Issue:8349 Topics: Adult; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Gluconates; Humans; Kidney Diseases; Kidney Tubules; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	1983
Clinical characteristics of human Leishmania braziliensis braziliensis infections. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1984, Volume: 78, Issue:6 Topics: Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Mucous Membrane; Organometallic Compounds	1984
[Experimental chemotherapy in cutaneous leishmaniasis. III. Effect of glucantime and humatin (P&D) on Leishmania garnhami and Leishmania braziliensis in hamsters]. Acta cientifica venezolana, 1984, Volume: 35, Issue:5-6 Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Drug Therapy, Combination; Female; Leishmania; Leishmaniasis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Sex Factors	1984
Apparent Glucantime failure in five patients with mucocutaneous leishmaniasis. The Journal of tropical medicine and hygiene, 1980, Volume: 83, Issue:4 Topics: Amphotericin B; Antigens; Antimony; Brazil; Female; Fluorescent Antibody Technique; Humans; Leishmania; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sorbitol	1980
Cutaneous leishmaniasis in mice: resistance to glucan immunotherapy, either alone or combined with chemotherapy. The American journal of tropical medicine and hygiene, 1982, Volume: 31, Issue:1 Topics: Animals; Antimony; Dose-Response Relationship, Immunologic; Female; Glucans; Immunotherapy; Leishmaniasis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Mononuclear Phagocyte System; Organometallic Compounds; Sorbitol	1982
Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:1 Topics: Adult; Amylases; Antimony Sodium Gluconate; Antiprotozoal Agents; District of Columbia; Humans; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Lipase; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancreatitis; Peru; Prospective Studies	1994
Mucocutaneous leishmaniasis and HIV. Dermatology (Basel, Switzerland), 1994, Volume: 189, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1994
Concurrent mucosal leishmaniasis and pulmonary tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23, Issue:4 Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Contraindications; Drug Therapy, Combination; Humans; Immunity, Cellular; Isoniazid; Leishmania; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary	1996
N-methylglucamine antimonate (SbV+): intralesional canine tegumentary leishmaniasis therapy. Parasite (Paris, France), 1998, Volume: 5, Issue:2 Topics: Animals; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Dogs; Female; Immunity, Cellular; Injections, Intralesional; Isoenzymes; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1998
Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients. Parasite immunology, 2000, Volume: 22, Issue:2 Topics: Adolescent; Adult; Animals; Antiprotozoal Agents; BCG Vaccine; Cell Division; Combined Modality Therapy; Female; Humans; Immunity, Cellular; Interferon-gamma; Interleukin-5; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Lymphocyte Activation; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mycobacterium bovis; Organometallic Compounds; Protozoan Vaccines; T-Lymphocytes, Helper-Inducer; Th1 Cells; Tuberculin	2000
Immunological selection for Leishmania (Viannia) braziliensis antigens. Annals of tropical medicine and parasitology, 2001, Volume: 95, Issue:5 Topics: Animals; Antigens, Protozoan; Antiprotozoal Agents; Biomarkers; Blotting, Western; Case-Control Studies; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2001
Cell surface carbohydrates and in vivo infectivity of glucantime-sensitive and resistant Leishmania (Viannia) guyjanensis cell lines. Parasitology research, 2001, Volume: 87, Issue:11 Topics: Animals; Antimony; Antiprotozoal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cricetinae; Disease Models, Animal; Drug Resistance; Glycosphingolipids; Lectins; Leishmania guyanensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Time Factors	2001
Oral leishmaniasis in a HIV-positive patient. Report of a case involving the palate. Oral diseases, 2002, Volume: 8, Issue:1 Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Diagnosis, Differential; Hepatitis C; Humans; Injections, Intravenous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mouth Diseases; Mouth Mucosa; Organometallic Compounds; Palate, Hard	2002
Effect of natural naphthoquinones in BALB/c mice infected with Leishmania amazonensis and L. venezuelensis. Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ), 1992, Volume: 43, Issue:4 Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Naphthoquinones; Organometallic Compounds; Plant Extracts	1992
Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. The American journal of tropical medicine and hygiene, 1992, Volume: 47, Issue:1 Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania; Leishmania braziliensis; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1992
Development of Leishmania (Viannia) panamensis lesions and relationship of numbers of amastigotes to lesion area on antimony-treated and untreated hamsters. The Journal of parasitology, 1991, Volume: 77, Issue:5 Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Skin	1991
Berberine derivatives as antileishmanial drugs. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:5 Topics: Animals; Antiprotozoal Agents; Berberine; Berberine Alkaloids; Body Weight; Cricetinae; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Skin	1990
Retention of antimony in hair during leishmaniasis treatment. Clinica chimica acta; international journal of clinical chemistry, 1989, Feb-22, Volume: 179, Issue:3 Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Child; Drug Administration Schedule; Hair; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol	1989
High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis. The American journal of tropical medicine and hygiene, 1985, Volume: 34, Issue:4 Topics: Adult; Amphotericin B; Antimony; Antimony Sodium Gluconate; Child; Gluconates; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1985
Antimony accumulation in hair during treatment of leishmaniasis. Clinical chemistry, 1987, Volume: 33, Issue:11 Topics: Antimony; Brazil; Hair; Humans; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Neutron Activation Analysis; Organometallic Compounds; Retrospective Studies; Sorbitol	1987
Intralesional glucantime in Leishmania braziliensis braziliensis infections. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1986, Volume: 80, Issue:1 Topics: Adult; Antimony; Antiprotozoal Agents; Child, Preschool; Female; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1986
Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases. The Journal of tropical medicine and hygiene, 1986, Volume: 89, Issue:6 Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Brazil; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1986